Literature DB >> 12772039

[GEOPTE Scale of social cognition for psychosis].

J Sanjuan1, L Prieto, J M Olivares, S Ros, A Montejo, F Ferrer, F Mayoral, M A González-Torres, M Bousoño.   

Abstract

INTRODUCTION: Despite the large number of scales to assess cognitive function, these are rarely used in clinical practice, both because of the time they require and because they do not give useful information to the clinician. The aim of this article is to present the characteristics and psychometric properties of a scale which aims, with its simplicity of use and design, to be of use in the clinical practice for measuring social cognition in psychosis.
METHODS: The new GEOPTE Scale gathers information from two sources: the patient's subjective perception of his/her deficits and that of the informant or caregiver. It consists of 15 items (7 for basic cognitive functions and 8 for social cognition). The scale was applied to 87 patients with a diagnosis of psychosis (according to DSM-IV), and general clinical data, clinical global impression, mood and degree of insight were gathered.
RESULTS: The GEOPTE Scale presented excellent internal consistency (Cronbach's alpha 0.84 for patient and 0.87 for informants). Factorial analysis identified two factors which explained a total variance of 39%. The first factor was related to the basic cognitive function items and the second to the social cognition items. Regarding the validity of the construct, the scores on the scale are closely related to clinical global impression, degree of insight and depressive symptoms.
CONCLUSIONS: The GEOPTE Scale for measuring social cognition in psychosis has an excellent psychometric behavior both in the degree of internal consistency and in correlation with clinical global variables, mood and degree of insight.

Entities:  

Mesh:

Year:  2003        PMID: 12772039

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  5 in total

1.  Subjective perceptions of cognitive deficits and their influences on quality of life among patients with schizophrenia.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Karine Baumstarck; Stephen E Gilman
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

2.  Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia.

Authors:  Qianqian Wei; Wei Yan; Rongrong Zhang; Xuna Yang; Shiping Xie
Journal:  Ann Gen Psychiatry       Date:  2022-02-10       Impact factor: 3.455

3.  Evidence of validity and reliability of the Spanish version of the “Observable Social Cognition: A Rating Scale” (OSCARS) in patients with schizophrenia.

Authors:  Angela López Martín; José Pérez-Revuelta; Edgar García-Spínola; Rocío Torrecilla-Olavarrieta; Ana Pérez Morenilla; Anais López García; José Ma Mongil-SanJuan; Carmen Rodríguez-Gómez; Juan M Pascual Paño; José Ma Villagrán-Moreno; Francisco González-Saiz
Journal:  Actas Esp Psiquiatr       Date:  2021-11-01       Impact factor: 1.667

4.  Anomalous self-experiences are related to general cognition deficits in schizophrenia.

Authors:  Marta Hernández-García; Marta Gómez-García; Eva Sotelo; Inés Fernández-Linsenbarth; Pilar Andrés-Olivera; Rubén de Alarcon-Gómez; María Fe Muñoz-Moreno; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-22       Impact factor: 5.270

5.  The association between smoking behaviour, social cognition and social functioning in patients with a non-affective psychotic disorder: A prospective follow-up study.

Authors:  Tobias E G Dekker; Heleen S van der Heijden; Frederike Schirmbeck; Therese van Amelsvoort; Agna A Bartels-Velthuis; Claudia J P Simons; Lieuwe de Haan; Jentien M Vermeulen
Journal:  Schizophr Res Cogn       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.